EDITORIAL
PDF
Cite
Share
Request
EDITORIAL
VOLUME: 30 ISSUE: 2
P: 0 - 0
June 2024

EDITORIAL

Arch Epilepsy 2024;30(2):0-0
No information available.
No information available
PDF
Cite
Share
Request

Editorial

Cihat Ünlü

Dear Colleagues,

It is my great pleasure to introduce the second issue of the “Journal of the Turkish-German Gynecological Association (J Turk Ger Gynecol Assoc)” in the publishing year of 2024. This issue is consisted of seven articles and one review that we hope you will read with interest. Also you may have the oppurtunity to read the letters to the editor. Here we share some of our favorite articles that were published in this issue of the journal.

Worldwide, polycystic ovarian syndrome (PCOS) is a common endocrine disorder among people of reproductive age. Increased levels of luteinizing hormone (LH) are frequently linked to PCOS, and this may have an impact on oocyte quality by promoting hyperandrogenism. You will read an article evaluating the impact of LH stimulation on IVF cycle outcomes in patients with PCOS.

Cytological specimens that do not fit the requirements for a high grade squamous intraepithelial lesion (HSIL) are categorized as “atypical squamous cells, cannot exclude high grade squamous intraepithelial neoplasia (ASC-H)” in the Bethesda 2014 classification. It is believed that in cases of HPV positive ASC-H, the prevalence of cervical intraepithelial neoplasia 2+ (CIN 2+) lesions ranges from 30% to 47%. However, there is little information in the literature currently in publication about the relationship between HPV subtypes and the probability of CIN 2+ lesions in ASC-H cytology. You will also read an article which assesses the correlation between CIN 2+ lesions and high-risk HPV subtypes among patients who presented with HPV-positive ASC-H cytology.

You will also have the opportunity to read a review discussing practical overview of management of postmenopausal endometriotic symptoms, use of hormone replacement therapy in postmenopausal women with a history of endometriosis and future risk of malignancy.

Dear Participants,

I would like to invite you to join us for our “Symposium on Current Approaches in Obstetrics and Gynecology”, which will be held in İstanbul on May 31-June 1 2024. The scientific programme of the symposium includes many distinguished scientists and researchers both from Turkey and Europe.

Additionally, I would like to remind you that our esteemed 15th Turkish-German Gynecology Congress, scheduled for April 23-April 27, 2025, in Antalya, is quickly coming. As previously said, our congress will be conducted in accordance with the strictest scientific guidelines, and we are constantly striving to enhance our conventional congress.

Dear Esteemed Readers,

Our published articles cover a wide range of obstetrics and gynecological topics. As can be seen, JTGGA is seeing a rise in citation counts as well. The utilization of keywords in the title, presentation of the study at conferences, use of the same form for your name and surname, sharing of your data on social media, and key word selection will all contribute to a higher number of citations. I would like to use this chance to express our gratitude to everyone who has supported our journal. We are appreciative to our readers, reviewers, and writers.

Please visit us online at www.jtgga.org and keep in touch with us by following us on Twitter @JtggaOfficial.

We are looking forward to receiving your valuable submissions, thank you in advance for your contributions.

Sincerely,

Prof. Cihat Ünlü, M.D.

Editor in Chief of J Turk Ger Gynecol Assoc

President of TGGF